Patent Assignment
Reel/Frame 027239/0310
Merger
Recorded: 2011-11-16
Pages: 4
Assignor
TRUBION PHARMACEUTICALS, INC.
Executed: 2010-08-12
Assignee
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
2273 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE, MARYLAND, 20850
Covered Properties
(2)
Binding Domain-Immunoglobulin Fusion Proteins
Application:
13/039,097 →
Publication:
US 2011/0223164
Recombinant signaling receptors for tumor gene therapy
Application:
60/385,691 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 21, 2002
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA
To: GENECRAFT, INC.
Reel/Frame 013402/0347 →
Assignment of Assignor's Interest
May 12, 2003
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA
To: GENECRAFT, INC
Reel/Frame 014742/0616 →
Assignment of Assignor's Interest
Nov 10, 2011
From: LEDBETTER, JEFFREY A.; HAYDEN-LEDBETTER, MARTHA; THOMPSON, PETER A.
To: GENECRAFT, INC.
Reel/Frame 027206/0537 →
Change of Name
Nov 10, 2011
From: GENECRAFT, INC.
To: TRUBION PHARMACEUTICALS, INC.
Reel/Frame 027212/0182 →